Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9181294
APP PUB NO 20140323425A1
SERIAL NO

14354044

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention describes the use of nucleoside analogs for the treatment of viral infections, in particular of an HIV infection, and also compositions comprising at least one of these analogs, and a method for evaluating the sensitivity to said treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)4 PLACE JUSSIEU PARIS 75005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Calvez, Vincent Paris, FR 10 17
Etheve-Quelquejeu, Melanie Choisy-le-Roi, FR 1 0
Marcelin, Anne-Genevieve Paris, FR 1 0
Sollogoub, Matthieu Paris, FR 3 3
Soulie, Cathia Paris, FR 2 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00